Hemorrhagic and Ischemic Stroke Treatment Devices Market Size and Scope 2026 to 2035

Report Id: 3432 Pages: 180 Last Updated: 02 February 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Hemorrhagic and Ischemic Stroke Treatment Devices Market :

Hemorrhagic & Ischemic Stroke Treatment Devices Market by Treatment-

  • Aneurysm & Hemorrhagic Stroke Interventions
    • By Device
      • Embolization Coiling Systems
        • Coated / Bioactive Coils
        • Bare Platinum Coils
      • Intrasaccular Flow Disruption Devices
        • Woven EndoBridge (WEB)
        • Luna Aneurysm Embolization System
        • Contour Neurovascular System
      • Flow Diversion Systems
        • Next-Generation / Surface-Modified Flow Diverters
        • Standard Flow-Diverting Stents (e.g., Pipeline)
      • Liquid Embolization Agents
        • Adhesive Liquid Embolics (NBCA)
        • Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
    • By Indication
      • Intracranial Aneurysm
      • AVM & AVF Embolization
      • cSDH (MMA Embolization)
  • Cerebral Angioplasty & Vascular Remodeling
    • Balloon Angioplasty Systems
    • Coil-Assisted Adjunctive Devices (Balloon-assisted and stent-assisted)
    • Intracranial & Carotid Stenting Systems
  • Ischemic Stroke Interventions (Mechanical Revascularization)
    • Aspiration-Based Thrombectomy Systems
    • Stent Retriever Systems
  • Ancillary & Procedural Access Devices
    • Microcatheters
    • Guiding & Distal Access Catheters
    • Access Sheaths & Wires

Hemorrhagic & Ischemic Stroke Treatment Devices Market

Hemorrhagic & Ischemic Stroke Treatment Devices Market, by End-user-

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Neurosurgery Centers

Hemorrhagic & Ischemic Stroke Treatment Devices Market, by Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Snapshot

Chapter 4. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ Mn), 2026–2035
4.8. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Penetration & Growth Prospect Mapping (US$ Mn), 2025–2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/Impact of AI and Next-Generation Technologies on Hemorrhagic & Ischemic Stroke Treatment Devices Industry Trends

Chapter 5. Hemorrhagic & Ischemic Stroke Treatment Devices Market Segmentation 1: By Treatment, Estimates & Trend Analysis
5.1. Market Share by Treatment, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Treatment:

5.2.1. Hemorrhagic & Ischemic Stroke Treatment Devices Outlook (Revenue, USD Million, 2022 - 2035)
5.2.2. Aneurysm & Hemorrhagic Stroke Interventions

5.2.2.1. By Indication

5.2.2.1.1. Intracranial Aneurysm
5.2.2.1.2. cSDH (MMA Embolization)
5.2.2.1.3. AVM & AVF Embolization

5.2.2.2. By Device

5.2.2.2.1. Embolization Coiling Systems
5.2.2.2.1.1. Bare Platinum Coils
5.2.2.2.1.2. Coated / Bioactive Coils

5.2.2.2.2. Flow Diversion Systems

5.2.2.2.2.1. Standard Flow-Diverting Stents (e.g., Pipeline)
5.2.2.2.2.2. Next-Generation / Surface-Modified Flow Diverters

5.2.2.2.3. Intrasaccular Flow Disruption Devices

5.2.2.2.3.1. Woven EndoBridge (WEB)
5.2.2.2.3.2. Contour Neurovascular System
5.2.2.2.3.3. Luna Aneurysm Embolization System

5.2.2.2.4. Liquid Embolization Agents

5.2.2.2.4.1. Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)
5.2.2.2.4.2. Adhesive Liquid Embolics (NBCA)

5.2.3. Ischemic Stroke Interventions (Mechanical Revascularization)

5.2.3.1. Stent Retriever Systems
5.2.3.2. Aspiration-Based Thrombectomy Systems
5.2.3.3. Cerebral Angioplasty & Vascular Remodeling

5.2.3.3.1. Balloon Angioplasty Systems
5.2.3.3.2. Intracranial & Carotid Stenting Systems

5.2.3.4. Coil-Assisted Adjunctive Devices (Balloon-assisted and stent-assisted)
5.2.3.5. Ancillary & Procedural Access Devices

5.2.3.5.1. Guiding & Distal Access Catheters
5.2.3.5.2. Microcatheters
5.2.3.5.3. Access Sheaths & Wires

Chapter 6. Hemorrhagic & Ischemic Stroke Treatment Devices Market Segmentation 2: By End Use, Estimates & Trend Analysis
6.1. Market Share by End Use, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End Use:

6.2.1. Hospitals
6.2.2. Ambulatory Surgical Centers (ASCs)

Chapter 7. Hemorrhagic & Ischemic Stroke Treatment Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market, Regional Snapshot, 2025 & 2035
7.2. North America

7.2.1. North America Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035

7.2.1.1. United States
7.2.1.2. Canada
7.2.1.3. Mexico

7.2.2. North America Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2022–2035
7.2.3. North America Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2022–2035

7.3. Europe

7.3.1. Europe Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035

7.3.1.1. Germany
7.3.1.2. United Kingdom
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe

7.3.2. Europe Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2022–2035
7.3.3. Europe Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2022–2035

7.4. Asia Pacific

7.4.1. Asia Pacific Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035

7.4.1.1. China
7.4.1.2. Japan
7.4.1.3. India
7.4.1.4. South Korea
7.4.1.5. Australia
7.4.1.6. Southeast Asia
7.4.1.7. Rest of Asia Pacific

7.4.2. Asia Pacific Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2022–2035
7.4.3. Asia Pacific Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2022–2035

7.5. Latin America

7.5.1. Latin America Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035

7.5.1.1. Brazil
7.5.1.2. Argentina
7.5.1.3. Rest of Latin America

7.5.2. Latin America Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2022–2035
7.5.3. Latin America Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2022–2035

7.6. Middle East & Africa

7.6.1. Middle East & Africa Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035

7.6.1.1. GCC Countries
7.6.1.2. South Africa
7.6.1.3. Rest of Middle East & Africa

7.6.2. Middle East & Africa Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2022–2035
7.6.3. Middle East & Africa Hemorrhagic & Ischemic Stroke Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2022–2035

Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions / Strategic Alliances
8.2. Company Profiles

8.2.1. Medtronic
8.2.2. Terumo Corporation
8.2.3. Balt
8.2.4. Scientia Vascular, Inc.
8.2.5. MicroPort Scientific Corporation
8.2.6. Johnson & Johnson (MedTech)
8.2.7. phenox GmbH (Wallaby Medical)
8.2.8. Acandis GmbH
8.2.9. B. Braun SE
8.2.10. Integra LifeSciences
8.2.11. Infinity Neuro LLC
8.2.12. Penumbra, Inc.
8.2.13. Boston Scientific Corporation
8.2.14. Stryker
8.2.15. Peter LAZIC GmbH
8.2.16. Vesalio Inc.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
9299
Security Code field cannot be blank!

Frequently Asked Questions

Hemorrhagic and Ischemic Stroke Treatment Devices Market Size is valued at USD 4.03 Bn in 2025 and is predicted to reach USD 7.65 Bn by the year 2035

Hemorrhagic and Ischemic Stroke Treatment Devices Market is expected to grow at a 6.8% CAGR during the forecast period for 2026 to 2035

Johnson & Johnson (MedTech), Medtronic, Scientia Vascular, Inc., MicroPort Scientific Corporation, phenox GmbH (Wallaby Medical), Acandis GmbH, B. Braun SE, Terumo Corporation, Balt, Integra LifeSciences, Infinity Neuro LLC, Stryker, Peter LAZIC GmbH, Vesalio Inc., Penumbra, Inc., Boston Scientific Corporation and Others.

Hemorrhagic and Ischemic Stroke Treatment Devices Market is segmented in Distribution by Treatment (Aneurysm & Hemorrhagic Stroke Interventions (By Device [Embolization Coiling Systems {Coated / Bioactive Coils, Bare Platinum Coils}, Intrasaccular Flow Disruption Devices {Woven EndoBridge (WEB), Luna Aneurysm Embolization System, Contour Neurovascular System}, Flow Diversion Systems {Next-Generation / Surface-Modified Flow Diverters, Standard Flow-Diverting Stents (e.g., Pipeline)}, Liquid Embolization Agents {Adhesive Liquid Embolics (NBCA), Non-Adhesive Liquid Embolics (Onyx, Squid, PHIL)}, By Indication [Intracranial Aneurysm, AVM & AVF Embolization, cSDH (MMA Embolization)]), Cerebral Angioplasty & Vascular Remodeling (Balloon Angioplasty Systems, Coil-Assisted Adjunctive Devices (Balloon-assisted and stent-assisted), Intracranial & Carotid Stenting Systems), Ischemic Stroke Interventions (Mechanical Revascularization) (Aspiration-Based Thrombectomy Systems, Stent Retriever Systems), and Ancillary & Procedural Access Devices (Microcatheters, Guiding & Distal Access Catheters, Access Sheaths & Wires)) and other.

North America region is leading the Hemorrhagic and Ischemic Stroke Treatment Devices Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying